Health News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

Sunbathing, considered risky by skin cancer experts, may actually reduce the risk of breast and other cancers, new research has found. Some women who had higher sun exposure had their risk of advanced breast cancer reduced by almost half, according to the scientific study. The researchers from Stanford University, who report their findings in the American Journal of Epidemiology this week, said: "This study supports the idea that sunlight exposure reduces risk of advanced breast cancer among women with light skin pigmentation." The Stanford cancer specialists measured 4,000 women aged 35 to 79, half of them diagnosed with breast cancer, for the effects of long-term sun exposure. Sun exposure may also protect against a number of other cancers, according to a second research team who studied more than four million people in 11 countries, including 416,000 who had been diagnosed with skin cancer. These results, reported in the European Journal of Cancer, show that the risk of internal cancers ... was lower among people living in sunny countries. The researchers said: "Vitamin D production in the skin seems to decrease the risk of several solid cancers, especially stomach, colo-rectal, liver and gall- bladder, pancreas, lung, female breast, prostate, bladder and kidney cancers." Sunlight plays a vital role in the production of beneficial vitamin D in the body. Although food provides some vitamin D, up to 90 per cent comes from exposure to sunlight.

Note: For many reliable, verifiable reports on promising cancer cures, click here.

A federal panel of scientists [has concluded] that an estrogen-like compound in plastic could be posing some risk to the brain development of babies and children. Bisphenol A, or BPA, [a component of polycarbonate plastic,] is found in low levels in virtually every human body. The decision by the 12 advisors of the Center for the Evaluation of Risks to Human Reproduction ... is the first official, government action related to the chemical. The scientists ranked their concerns about BPA, concluding they had "some concern" about neurological and behavioral effects in fetuses, infants and children, but "minimal" or "negligible" concern about reproductive effects. The findings put the panel roughly in the middle -- between the chemical industry, which has long said there is no evidence of danger to humans, and the environmental activists and scientists who say it is probably harming people. Environmentalists lambasted the panel, saying it had minimized the risks and ignored important research. "Only the chemical industry agrees with the decision that BPA has little or no human health risks. That by itself should speak volumes about the corrupted process endorsed by the panel today," said Dr. Anila Jacob of the Environmental Working Group. The panel's preliminary report on BPA was drafted by a private consulting firm with financial ties to the chemical industry. The National Toxicology Program fired the company but ruled that the report was unbiased. The panel rejected several dozen animal studies that found reproductive effects. The decision to reject the studies has been controversial with toxicologists.

They might be called China’s renegade businessmen, small entrepreneurs who are experts at counterfeiting and willing to go to extraordinary lengths to make a profit. But just how far out of the Chinese mainstream are they? Cutting corners or producing fake goods is not just a legacy of China’s initial rush toward the free market three decades ago but [is] still woven into the fabric of the nation’s thriving industrial economy. It is driven by entrepreneurs who are taking advantage of a weak legal system, lax regulations and a business culture where bribery and corruption are rampant. “This is cut-throat market capitalism,” said Wenran Jiang, a specialist in China who teaches at the University of Alberta. Since this country’s economic reforms began to take root in the 1980s, businesses have engineered countless ways to produce everything from fake car parts, cosmetics and brand name bags to counterfeit electrical cables and phony Viagra. Counterfeiting rings are broken nearly every week; nonetheless, the government seems to be waging a losing battle against the operations. Dozens of Chinese cities have risen to prominence over the last two decades by first specializing in fake goods, like Wenzhou, which was once known for selling counterfeit Procter & Gamble products, and Kaihua in Zhejiang province, which specialized in fake Philips light bulbs. For a time, people even derided the entire province of Henan as the capital of substandard or fake goods, like medicines that could make you miraculously grow taller.

Note: The fact that China recently sentenced to death the former head of the State Food and Drug Administration may show that China is trying to address the problem, yet corruption is rampant in the drug industries of China, the U.S., and most other countries.

The March 16 recall of 91 pet food products manufactured by Menu Foods wasn't big news at first. Early coverage reported only 10-15 cats and dogs dying. I'm a contributing editor for a nationally syndicated pet feature ... and all of us there have close ties to the veterinary profession. What we were hearing from veterinarians wasn't matching what we were hearing on the news. Although ... Menu Foods started getting complaints as early as December 2006, FDA records state the company received their first report of a food-related pet death on February 20. One week later, on February 27, Menu started testing the suspect foods. Three days later, on March 3, the first cat in the trial died of acute kidney failure. Nearly one month passed from the date Menu got its first report of a death to the date it issued the recall. At that point, Menu had seen a 35 percent death rate in their test-lab cats. We started a database for people to report their dead or sick pets. As of March 31, the number of deaths alone was at 2,797. Pet owners were encouraged to report deaths and illness to the FDA. But ... there was no place on the agency's Web site to do so. The FDA kept confirming a number it had to have known was only the tip of the iceberg. It prevented veterinarians from having the information they needed to treat their patients. It allowed the media to repeat a misleadingly low number ... preventing a lot of people from really grasping the scope and implication of the problem. An import alert buried on the FDA Web site ... identified the Chinese company that is the source of the contaminated gluten -- gluten that is now known to be sold not only for use in animal feed, but in human food products, too.

Note: If you want to understand how the FDA sometimes works to support big industry at the expense of our health (and in this case the health of our pets), the entire article is a big eye-opener. Click here for more.

The U.S. Food and Drug Administration said on Tuesday it would make organizational changes to improve internal communication about potential risks that emerge after a new drug reaches the market. The move is part of the agency's response to an Institute of Medicine (IOM) report that sharply criticized the FDA's drug safety oversight and called for more staffing, funding and power to police the drug industry. The September 2006 report also found a "dysfunctional" FDA structure that hindered the agency's ability to protect public health. The IOM experts said they found FDA officials had trouble managing scientific disagreements among staff and downplayed some concerns by safety reviewers who monitor drugs after they win approval. On Tuesday, the agency said it was "making specific organizational and management changes to increase communications among FDA review staff and safety staff." The announcement came as lawmakers prepare to debate critical funding legislation for the agency that could become a vehicle for drug safety reforms. The FDA had requested the IOM report after it came under harsh criticism for its handling of Merck & Co. Inc.'s withdrawn arthritis drug Vioxx and other medicines. Merck pulled Vioxx from the market in 2004, five years after its approval, because of a link to heart attacks and strokes.

Three judges emerged after years of secret deliberation to rule that Europe had imposed a de facto ban on GM [genetically modified] food imports between 1999 and 2003, violating WTO rules. The court also ruled that Austria, France, Germany, Greece, Italy and Luxembourg had no legal grounds to impose their own unilateral import bans. Actually, the judges said much more, but in true WTO style no one has been allowed to know what. A few bureaucrats in the US, EU, Argentina and Canada have reportedly seen the full 1,045-page report, and an edited summary of some of its conclusions has been leaked. But no one, it seems, will take responsibility for the ruling, which may force the EU to pay hundreds of millions of dollars to compensate some of the world's most heavily subsidised farmers, and could change the laws of at least six countries that have imposed GM bans. It is now clear that the real reason the US took Europe to the WTO court was...to make it easier for its companies to...open regulatory doors in China, India, south-east Asia, Latin America and Africa, where most US exports now go. This is where millions of tonnes of US food aid heads, and where US GM companies are desperate to have access, buying up seed companies and schmoozing presidents.

Note: For an excellent summary of the dangers of genetically modified foods that Americans are already eating without their knowledge, see http://www.WantToKnow.info/deception10pg

The first session of the 109th Congress is over, but lawmakers and interest groups are still sorting out what surprises may have been buried in its final bills. A clause added here or lifted there can shift the fortunes of whole industries and regions. The year ended in a crush of tough negotiations, late-night votes, and hastily printed bills so vast that few lawmakers had time to read them. Early in the morning on Dec. 19, lawmakers got their first glimpse of the 774-page final version of a nearly $40 billion spending cut bill. The time? 1:12 a.m. House members had to vote on the measure just four and a half hours later. While the rules say that a conference agreement can't include elements that haven't been voted in either the House or Senate...they are often violated. Senate negotiators were stunned to learn that GOP House leaders had added a whole campaign-finance bill to the final conference report on the Defense authorization bill they had already signed. The new language...was added to the bill after the conference had closed. Another provision, granting immunity from liability to manufacturers of flu vaccine, was added at the last minute to the FY 2006 Defense Appropriations bill.

Note: Few people are aware that in clear violation of Congressional rules, the Patriot Act was passed only hours after significant changes were made to what had been previously agreed upon. No members of Congress had the opportunity to read all of these changes, which eroded significantly more civil rights and liberties than had been previously agreed. For more on this, click here.

The two sides in the debate over genetically modified crops issued warring reports assessing the first decade of the technology this week, as the industry's sunny view clashed with the darker vision of critics. The world's farmland planted with biotechnology crops reached 252 million acres in 2006, the industry-backed International Service for the Acquisition of Agri-Biotech Applications calculated in a report ... that promotes the products as solutions for hunger and future fuel demand. The report concluded that biotechnology boosts crop yields and benefits the environment. That view was challenged by Friends of the Earth International and the Center for Food Safety in a report released Wednesday. The two groups argued that engineered plants don't produce larger harvests than conventional varieties, are often more vulnerable to drought and have increased the use of pesticides. The United States and Argentina host about 70 percent of the world's biotech crop acreage, both sides said. But adoption of the technology is growing at a faster rate in developing countries than in industrialized nations, according to the International Service. About 10 million farmers in 22 countries sow genetically modified crops, it said. The dominant biotech crop is soybeans, with 57 percent of world acreage, followed by maize, cotton and canola. Opponents said the crops are mainly a boon to agribusiness and big agricultural chemical companies trying to increase sales of seeds, weed-killers and bug sprays. Biotech crop seeds are often engineered to be resistant to the herbicides or pesticides sold by the same company.

Note: For reliable information showing that you may be eating genetically modified food every day which scientific experiments have repeatedly demonstrated can cause sickness and even death, click here.

Drug companies fund a growing number of the studies in leading psychiatric journals, and drugs fare much better in these company-funded studies than in trials done independently or by competitors, researchers reported Wednesday. About 57% of published studies were paid for by drug companies in 2002, compared with 25% in 1992, says psychiatrist Igor Galynker of Beth Israel Medical Center in New York City. His team looked at clinical research in four influential journals: American Journal of Psychiatry, Archives of General Psychiatry, Journal of Clinical Psychiatry and Journal of Clinical Psychopharmacology. In the report, released at the American Psychiatric Association meeting in Toronto, reviewers did not know who paid for the studies they evaluated, Galynker says. There were favorable outcomes for a medication in about: eight out of 10 studies paid for by the company that makes the drug; five out of 10 studies done with no industry support; three out of 10 studies done by competitors of the firm making the drug. As drug companies increasingly fund research that yields favorable outcomes for their drugs, there may be a built-in bias because journals are reluctant to publish studies with negative or inconclusive findings.

Note: To learn more about the astonishing profits and power of the major drug companies, read our concise summary of a major insider's research at http://www.WantToKnow.info/healthcoverup

Note: We usually limit ourselves to information from sources known and respected by the public. For this message, we're making an exception. Jeff Rense of rense.com is a radio personality and researcher of major cover-ups with no strong credentials other than a large following of people convinced of the quality of his work. His popular website receives millions of visits a month. Below is vital information everyone should know.

Royal Raymond Rife was a brilliant scientist born in 1888 and died in 1971. He received 14 major awards and honors and was given an honorary Doctorate by the University of Heidelberg for his work. By 1933, he had ... constructed the incredibly complex Universal Microscope, which ... was capable of magnifying objects 30,000 times their normal size. With this incredible microscope, Rife became the first human being to actually see a live virus. In 1934, the University of Southern California appointed a Special Medical Research Committee to bring terminal cancer patients ... to Rife's San Diego Laboratory and clinic for treatment. The team included doctors and pathologists assigned to examine the patients - if still alive - in 90 days. After the 90 days of treatment, the Committee concluded that 86.5% of the patients had been completely cured. On November 20, 1931, forty-four of the nation's most respected medical authorities honored Royal Rife with a banquet. But by 1939, almost all of these distinguished doctors and scientists were denying that they had ever met Rife. The last thing in the world that the pharmaceutical industry wanted was ... a painless therapy that cured ... terminal cancer patients and cost nothing to use but a little electricity. It might give people the idea that they didn't need drugs. Medical journals, supported almost entirely by drug company revenues and controlled by the AMA, refused to publish any paper by anyone on Rife's therapy. Rife technology became public knowledge again in 1986 with the publication of The Cancer Cure That Worked, by Barry Lynes, and other material about Royal Rife and his monumental work.

Note: For excellent video documentaries, including interviews with Royal Rife: http://www.rifevideos.com. For an excellent website focused on Rife's work, click here. For more reliable, verifiable information on health cover-ups, click here.

In its first year in office, the Trump administration introduced a solitary new environmental rule aimed at protecting the public from pollution. It was aimed [at] dentists. About 5 tons of mercury, a dangerous toxin ... are washed away from dental offices down drains each year. In Trump’s first day in the White House, the administration told the Environmental Protection Agency (EPA) to withdraw an Obama-era plan that would require dentists to prevent this mercury from getting into waterways. But in June, the rule was unexpectedly enacted. This apparent change of heart followed legal action filed by green groups, part of a cascade of courtroom standoffs. In July, a federal court ruled that the EPA couldn’t suspend rules designed to curb methane emissions from new oil and gas wells. This was followed by a hasty retreat in August when the EPA agreed to not delay new standards to reduce smog-causing air pollutants, the day after 15 states and environment groups sued. Then, in December, a federal court told the EPA it couldn’t delay a new standard for dangerous levels of lead in paint and dust. Many of these legal problems have stemmed from the sheer pace of the rollbacks – required public comment periods have been set aside in some cases, any rationale for repeal or delay has been missing in others. Opponents of the administration also believe there is a determination to expunge every vestige of Obama’s environmental legacy, regardless of merit.

Note: Hundreds of people have left or been forced out of the Environmental Protection Agency since the current administration took office. For more along these lines, see concise summaries of deeply revealing government corruption news articles from reliable major media sources.

The medical industry produces plenty of waste ... in addition to using loads of energy. The health care sector accounts for 10 percent of carbon pollution in the United States. “Unfortunately, the way we practice medicine today has a negative impact on our environment and, in turn, human health,” [said NYU Langone Health professor Cassandra Thiel]. She and her colleagues decided to examine the problem of health industry emissions to see if they could find greener approaches. They studied cataract surgeries performed in a health care center in India, the Avravind Eye Care System, which is seen as a model for its low cost and excellent results. Because the United States and other developed nations rely largely on single-use materials in surgery, “we wanted to examine whether a different approach, where surgical supplies are mostly reused, could make a bigger impact on reducing emissions,” she said. Their paper appears in the Journal of Cataract and Refractive Surgery. “India currently performs over seven million cataract surgeries a year,” Thiel said. “If all were done with the U.K.’s process, they would emit nearly one million metric tons of greenhouse gases. If all were conducted with Aravind’s process, they would emit about 40,000 metric tons of greenhouse gasses. This difference is equivalent to removing over 230,000 passenger vehicles from the road.”.

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

Wild dolphins are struggling with high levels of mercury and industrial pollution in the oceans off the coasts of Florida and South Carolina. The pollution is putting their immune system on constant alert, which makes it less able to fight off bacteria, fungus, viruses and parasites in the water, according to a study in the journal PLOS ONE. The industrial pollution was strongest in the oceans near Charleston, South Carolina in the US. Organic compounds released into the water accumulate in microorganisms – that are eaten by fish, which are in turn eaten by dolphins. The toxins become more concentrated in each step of the food chain. Large amounts of mercury were found in dolphins that live in the Indian River Lagoon. Previous research has shown that the Indian River Lagoon dolphins developed a fungal skin disease because of their suppressed immune systems and new viruses. Some of these are also potentially infectious to humans. By comparison, the dolphins kept in the Georgia Aquarium had fewer diseases and their immune systems were under a lot less stress. This is because the environment at the aquarium is more tightly controlled for water quality. Keeping dolphins in captivity comes with its own impact on the overall health of the mammals. Dolphins are highly intelligent and have complex social structures that can't be maintained in small tanks. As a result, dolphins in captivity live shorter lives than those in the wild.

Note: For more along these lines, see concise summaries of deeply revealing news articles on dolphins and whales from reliable major media sources.

The DNA in our cells, which contains the genetic instructions that make us human, is passed on from parent to child along an unending line of generations. However, as recent experiments in mice have demonstrated, there is more to transgenerational inheritance than that. “Learned” experiences, which do not alter the underlying genetic material, can be passed on from one generation to the next - in mice, fruit flies, and possibly even humans. A new study ... has shown that such “epigenetic” memories can be passed down for 14 generations. This is the longest maintenance of transgenerational environmental memory observed in any animal to date. The researchers inserted a gene coding for fluorescent protein in [a species of] worms that, when activated, made them glow brightly under ultraviolet light. If the worms were kept at 20 degrees Celsius (68 degrees Fahrenheit), the array of transgenes was less active ... but when they were exposed to a warmer temperature of 25 degrees Celsius (77 degrees Fahrenheit), the activity of the transgenes was significantly increased. When these worms were moved back to the cooler temperature, their transgenes remained active - a sign that they were retaining the memory of their exposure to warmth. This high activity level was passed on for seven subsequent generations. Keeping worms at 25 degrees for five generations led to the transgene activity being maintained for at least 14 generations.

Note: Read more about the emerging science of epigenetics, which clarifies how environmental factors and lifestyle choices influence our genetic makeup. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources.

This season’s flu vaccine seems to be working pretty well, weakening the punch of a nasty bug that’s going around, U.S. health officials said Thursday. Preliminary figures suggest the vaccine is 48 percent effective. That’s not bad since the strain that’s making most people sick is one of the worst. Experts consider it a good year when a flu vaccine is 50 to 60 percent effective. The flu vaccine is changed each year based on the best guess at which three or four strains will be the biggest problem for the next season. The current vaccine is a good match, and includes a strain of Type A H3N2 flu virus that is causing most illnesses. That wasn’t the case with the vaccine two years ago when the same bug dominated and caused a very bad flu season. As of Feb. 10, the CDC shipped out 145 million doses of the flu vaccine. Flu shots are recommended for virtually all Americans age 6 months or older. Health officials were worried that fewer kids would get vaccinated this season after they stopped endorsing a popular nasal spray version. Research showed it didn’t work well for another common type of flu. But vaccination rates for kids by November were about the same as the year before.

Note: A National Institute of Health study found in 2007 that flu shots do not protect the elderly. More recent studies have shown that some flu shots actually increase the risk of infection. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.

In June, Dr. Barbara Bowman, a high-ranking official within the Centers for Disease Control and Prevention, unexpectedly departed the agency, two days after information came to light indicating that she had been communicating regularly with - and offering guidance to - a leading Coca-Cola advocate seeking to influence world health authorities on sugar and beverage policy matters. Now, more emails suggest that another veteran CDC official has similarly close ties to the global soft drink giant. Michael Pratt, Senior Advisor for Global Health in the National Center for Chronic Disease Prevention and Health Promotion at the CDC, has a history of promoting and helping lead research funded by Coca-Cola. Pratt also works closely with the nonprofit corporate interest group set up by Coca-Cola called the International Life Sciences Institute (ILSI), emails obtained through Freedom of Information requests show. His work ... includes a position as a professor at Emory University, a private research university in Atlanta that has received millions of dollars from the Coca-Cola Foundation and more than $100 million from famed longtime Coca-Cola leader Robert W. Woodruff. Coca-Cola’s financial support for Emory is so strong that the university states on its website that “it’s unofficially considered poor school spirit to drink other soda brands.” The mission of the CDC is protecting public health. It is problematic for agency officials to collaborate with a corporate interest that has a track record of downplaying the health risks of its products.

Note: For more on the close ties between Coca Cola and the government, read this revealing article. For more, see concise summaries of deeply revealing news articles on corruption in government and in the food system.

More than 40 nations are proposing to boost their 'bioeconomy' - the part of the economy based in biology and the biosciences. Around US$2 trillion of products in agriculture and forestry, food, bioenergy, biotechnology and green chemistry were exported worldwide in 2014, amounting to 13% of world trade, up from 10% in 2007. These sectors are central to at least half of the UN Sustainable Development Goals (SDGs), from food security to ensuring energy access and health. But conflicting national priorities make it hard to align bioeconomy policies to meet the SDGs on a global scale. Ecological sustainability is a prime concern in rich and industrializing countries; inclusive rural development and equitable sharing of resources is central in developing countries. Decisions made in one place may be felt elsewhere. A global bioeconomy must rebuild natural capital and improve the quality of life for a growing world population. It should balance managing common goods, such as air, water and soil, with the economic expectations of people. Three types of innovation will be needed: technological (such as systems to reduce emissions), organizational (changes in institutional behaviour) and social (such as job creation).

Note: For an excellent, more recent discussion on the global bioeconomy, see this informative article.

People are firmly in charge of much of their own risk of cancer. The team at Harvard Medical School calculated that 20 to 40 percent of cancer cases, and half of cancer deaths, could be prevented if people quit smoking, avoided heavy drinking, kept a healthy weight, and got just a half hour a day of moderate exercise. They used data from long-term studies of about 140,000 health professionals who update researchers on their health every two years for the analysis, published in the Journal of the American Medical Association’s JAMA Oncology. These figures increased to 40 percent to 70 percent when assessed with regard to the broader U.S. population of whites, which has a much worse lifestyle pattern than our cohorts,” Dr. Mingyang Song and Dr. Edward Giovannucci of Harvard Medical School wrote. "The findings of the current study provide strong support for the argument that a large proportion of cancers are due to environmental factors and can be prevented by lifestyle modification." By "environmental," they mean non-genetic causes. To a scientist, environment includes diet, exercise and other factors. “Cancer is preventable,” Dr. Graham Colditz and Dr. Siobhan Sutcliffe of Washington University School of Medicine ... agreed in a commentary. “In fact, most cancer is preventable - with estimates as high as 80 percent to 90 percent for smoking-related cancers ... and as high as 60 percent for other common, lifestyle-related cancers.”

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

The Campbell Soup Company may become the first major U.S. food company to list genetically modified organisms, or GMOs, in its ingredients lists nationwide as it threw its weight behind a national labeling standard. The company announced its support on Thursday for federal regulation of GMO standards, noting it is in favor of federal legislation that would allow the U.S. Food and Drug Administration and the U.S. Department of Agriculture to regulate which foods can be labeled GMOs. The company's support for federal legislation comes as Vermont prepares to implement the Vermont Genetically Engineered Food Labeling Act, which would require a GMO label on food by July 1, 2016, if the food is "entirely or partially produced with genetic engineering." Campbell posted an example of that label on its website and said it was preparing to expand the GMO labeling nationwide even without federal regulations, but to do so would need guidance from the FDA and USDA. The company estimates the new labels could be implemented in approximately 12 to 18 months after it gets guidance from the federal agencies. There is currently no federal standard for what food would constitute a GMO, unlike a food item that is deemed USDA Organic. The World Health Organization defines a GMO as "foods derived from organisms whose genetic material (DNA) has been modified in a way that does not occur naturally, e.g. through the introduction of a gene from a different organism."

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

A potential anti-Alzheimer’s drug tested in mice unexpectedly reduced general symptoms of aging, according to a study led by Salk Institute researchers. The study examined the effects of the drug, J147, in a strain of mice bred to rapidly age and show signs of senescence. It is the second mouse model to show effectiveness. Besides improved cognition compared to controls, the treated mice exhibited better metabolism, reduced blood leakage from microvessels in the brain, and other improvements. Researchers ... published the study Wednesday in the journal Aging. Abrexa Pharmaceuticals, a San Diego company formed to commercialize J147, has licensed the compound from Salk. The drug is to be tested for Alzheimer's, not for anti-aging properties. Derived from a spice in curry, [J147] was developed ... based on the observation that people in India, where curry is widely consumed, rarely get Alzheimer's. The potential drug has been previously tested in Alzheimer's model mice. It was found to have memory-enhancing effects. The new study, showing effectiveness in another strain of mice, lends further credence to J147's usefulness.

Note: For more on J147 see this article in U.S. News & World Report (particularly the video at the bottom of the page) or do a search on J177. Some are claiming that big Pharma won't study this promising drug as it won't make big enough profits for them.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.